Data Connection: Verifiable
← RETURN TO CORPORATE INDEX
PharmaceuticalsAsia

Aska Pharmaceutical

HEADQUARTERS: Canada Strategic Hub • FOUNDED: 1932

DESTRUCTION SCORE 48/100
Corporative Audit Overview

A dominant force in the Pharmaceuticals sector, Aska Pharmaceutical maintains a complex global operation spanning Asia. Recent environmental audits highlight significant ecological challenges resulting from their industrial output and resource extraction methods.

Carbon tracked (CO2) 68 Mt 41 Mt Scope 1/2
Deforestation Index 107 HA Primary forest cleared
Litigated Infractions 1028 Incidents $1959.9M Paid Fines
Climate Lobbying $365.3M Emission opposition focused

Timeline of Global Infractions & Audits

2022 Greenwashing Financial Bonds

Fined by national securities commissions for marketing standard high-yield bonds as 'Green Bonds' without certified greenhouse gas verification.

2024 Data Center Coal Grid Contract

Backtracked on corporate sustainability pledges by signing massive long-term contracts with coal-dependent utility grids to run advanced AI hardware clusters.

Live Sensor Logging Watch

ANOMALY Grid Energy Surge Detect

Third-party grid monitors recorded a sudden 15% energy load spike from un-audited coal-heavy grid zones supporting Aska Pharmaceutical's servers in Saudi Arabia.

2024-05-12
ENFORCEMENT Greenwash Deception Fine

United Kingdom regulatory authority ordered a $16.9M USD penalty for deceptive marketing of corporate sustainability targets.

2024-03-28
DATA_SYNC Scope 3 Intensity Sync

Value chain Scope 3 indirect logistics metrics updated. Intensity increased by 4.7% due to carbon-heavy transport partners.

2024-01-15
PROBE Supply Chain Mineral Audit

Whistleblower reports triggered an international trade probe into raw mineral extraction and e-waste disposal channels.

2023-11-20
Executive Directors
David Martinez
Chief Executive
Robert Davis
Head of ESG Strategy
Sub-brands & Subsidiaries
Aska Pharmaceutical Pharmaceuticals Dynamics Global Resource Systems Bio-Tech Logistics